Liraglutide: Liraglutide holds a significant position in the Liraglutide and Semaglutide Market Size, accounting for approximately 74.3% of total consumption volume in 2024, reflecting its long-standing presence in diabetes and obesity treatment protocols
Water, Centella Asiatica Extract (13.5%), Butylene Glycol, Dipropylene Glycol, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Niacinamide (1,000ppm), Glutathione (1,000ppm), Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Sodium Hyaluronate, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Propanediol, Disodium EDTA, Glyceryl Acrylate/Acrylic Acid Copolymer, Cellulose Gum, Xanthan Gum, Inulin, Cellulose, Glucose, Fructose, Polyglucuronic Acid, Hydroxyethyl Urea, Ethylhexylglycerin, Hydroxyacetophenone, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Glycerin, Dipotassium Glycyrrhizate, 1,2-Hexanediol, Carbomer, Arginine Ingredients subject to change at manufacturer's discretion
KEY FEATURES GLP-1 Shot Tracker Easily log your weekly shots of Semaglutide, Tirzepatide, or other GLP-1 medications
Additionally, women without type 2 diabetes tend to experience more pronounced weight loss compared to those managing both PCOS and diabetes
Many patients experience some weight regain after stopping GLP-1 medications because appetite-regulating hormones return to baseline levels
Our team offers insurance verification support and self-pay options when coverage is not available
